Disc Medicine Sells $720k: CFO Moves After FDA Rejection
A biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
Fund reallocation matters when priorities shift. This intro explains why adjusting allocations supports your financial plan.
21,833 articlesA biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
A rising crypto platform seeks to give retail investors access to IPO pricing by delivering on-chain, tokenized share...
This oddity tech stock is making waves again. With a larger share repurchase plan and improving cash flow, the stock ...
Backlogs can unlock revenue visibility, but they can also mask quality issues. This article explains how to assess or...
Two Nevada lawmakers demand a comprehensive plan to fix safety oversight gaps tied to Elon Musk's Boring Co. tunnelin...
The Iran-backed Houthis say they fired on Israel, marking their first missile strike in the current conflict. Israel ...
As demand for copper and gold persists, two mining stocks stand out this May. This guide explains why FCX and Barrick...
The chatter around ad tech is hard to ignore, and Trade Desk sits at the center. This deep dive explains what fuels t...
Looking for reliable income in 2026? This guide breaks down how to find the best high-yield dividend stocks, avoid di...
When sandisk stock just popped, traders watched for AI data-center demand and memory-market signals. This article bre...
A new wave of skepticism surrounds the Fed after a high-profile critique from a former governor. This piece explains ...
AI is accelerating faster than many investors expect. These linked stocks best illustrate a powerful path: pairing Al...